dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2021-06-25T10:24:09Z
dc.date.accessioned2022-12-19T22:11:06Z
dc.date.available2021-06-25T10:24:09Z
dc.date.available2022-12-19T22:11:06Z
dc.date.created2021-06-25T10:24:09Z
dc.date.issued2021-02-01
dc.identifierZebrafish, v. 18, n. 1, p. 55-65, 2021.
dc.identifier1545-8547
dc.identifierhttp://hdl.handle.net/11449/205950
dc.identifier10.1089/zeb.2020.1945
dc.identifier2-s2.0-85101501911
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5386547
dc.description.abstractParkinson's disease (PD) is a chronic neurodegenerative disorder mainly attributed to the progressive loss of dopaminergic neurons in the substantia nigra, which leads to uncontrolled voluntary movements causing tremors, postural instability, joint stiffness, and speech and locomotion difficulties, among other symptoms. Previous studies have shown the participation of specific peptides in neurodegenerative diseases. In this context, the present work analyzed changes in the peptide profile in zebrafish brain induced to parkinsonian conditions with 6-hydroxydopamine, using isotopic labeling techniques plus mass spectrometry. These analyses allowed the relative quantitation and identification of 118 peptides. Of these, nine peptides showed significant changes, one peptide was increased and eight decreased. The most altered sequences were fragment of cytosolic and extracellular proteins related to lipid metabolism and dynamic cytoskeleton. These results open new perspectives of study about the function of peptides in PD.
dc.languageeng
dc.relationZebrafish
dc.sourceScopus
dc.subjectmass spectrometry
dc.subjectneurodegenerative disease
dc.subjectpeptidomics
dc.subjectzebrafish
dc.titlePeptide Profile of Zebrafish Brain in a 6-OHDA-Induced Parkinson Model
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución